THU0626 Cost-effectiveness of early treatment of acpa positive rheumatoid arthritis patients with abatacept

AS Neubauer; C Minartz; KH Herrmann; R Postema; C Baerwald

doi:10.1136/annrheumdis-2017-eular.4312

Article info

PDF

Poster Presentations

Public health, health services research and health economics

THU0626 Cost-effectiveness of early treatment of acpa positive rheumatoid arthritis patients with abatacept

Free

Authors

AS Neubauer 1Institute for Health Economics (IfG, IfGPh) PubMed articles Google scholar articles
C Minartz 1Institute for Health Economics (IfG, IfGPh) PubMed articles Google scholar articles
KH Herrmann 2Bristol-Myers Squibb, Muenchen, Germany PubMed articles Google scholar articles
R Postema 3Bristol-Myers Squibb, London, United Kingdom PubMed articles Google scholar articles
C Baerwald 4Rheumatology Unit, University of Leipzig, Leipzig, Germany PubMed articles Google scholar articles

Citation

Neubauer A, Minartz C, Herrmann K, et al

THU0626 Cost-effectiveness of early treatment of acpa positive rheumatoid arthritis patients with abatacept

Annals of the Rheumatic Diseases 2017;76:442-443.

Publication history

First published June 15, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password